Explore 3 Stock Ideas & Industry Insights Download Free Report

Holista Colltech Ltd

Company price
0.033 AUD 0.00(0%)
Last update at 2026-11-12T04:34:00Z
VOLUME
8755
Market Cap
12.14M

Momentum Score

…

Holista Colltech Limited operates as a research-driven biotech company in Australia, Malaysia, and the United States. The company operates through Supplements, Ovine Collagen, Infection Control Solutions, Food Ingredients, and Corporate segments. It manufactures and wholesales dietary supplements; cosmetic grade collagen; infection control solutions; and healthy food ingredients, including low-glycemic index (GI) bread, noodles/pasta, and flatbreads, as well as low-calorie/low-GI sugar substitutes. Further, it offers GI LiTE, a premix glycemic index reducer, and LOGIC, a sweetening solution alternative for health-conscious consumers. The company also offers biogenic particles, low fat chips, and water soluble technology. Holista Colltech Limited is based in Subiaco, Australia.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.03
Low
0.03
High
52 Week Price Range
0.03
Low
0.09
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Holista CollTech Ltd is an Australia-listed company that appears positioned to develop and commercialise collagen-related and other health ingredient products for medical, cosmetic and nutraceutical applications, based on its public disclosures. Long-term growth may be supported by rising global demand for functional ingredients and ageing-population trends, and investors may find exposure to niche ingredient technologies and potential partner-led scaling appealing.

Principal risks include early-stage commercialisation and product-development execution, regulatory approval requirements and small-cap liquidity and funding constraints.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.03
Dividend Yield
-
Revenue TTM
5.89M
Revenue Per Share
0.02
Gross Profit TTM
3.13M
Debt / Equity
1.42
ROE
-666.92%
Net Debt
-0.57M
ROCE
26236.22%
Diluted EPS TTM
-0.01

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax -0.91M 0.07M -4.85M -1.36M -1.20M
Minority interest - 0.00M 0.11M 0.07M 0.10M
Net income -0.95M -0.08M -4.81M -1.52M -1.36M
Selling general administrative - 2.34M 2.51M 2.89M 2.80M
Selling and marketing expenses - 0.85M 0.81M 1.03M 0.99M
Gross profit 0.77M 0.09M 0.37M 4.24M 4.59M
Reconciled depreciation - 0.10M 0.24M 0.27M 0.20M
Ebit -0.84M 0.20M -4.76M -1.30M -1.16M
Ebitda -0.79M 0.30M -4.52M -1.02M -0.96M
Depreciation and amortization 0.05M 0.10M 0.24M 0.27M 0.20M
Operating income -0.84M 0.63M -2.26M -1.30M -1.16M
Other operating expenses 6.61M 4.97M 8.21M 9.66M 9.27M
Interest expense 0.11M 0.12M 0.09M 0.07M 0.05M
Tax provision - 0.17M 0.07M 0.16M 0.15M
Interest income - 0.01M 0.00M 0.02M 0.06M
Net interest income - -0.11M -0.09M -0.07M -0.04M
Extraordinary items - 0.02M -0.00M - -
Income tax expense 0.04M 0.17M 0.07M 0.16M 0.15M
Total revenue 5.76M 5.60M 5.95M 8.24M 8.02M
Total operating expenses 1.61M 2.73M 4.88M 5.66M 5.84M
Cost of revenue 4.99M 5.51M 5.58M 4.00M 3.43M
Total other income expense net -0.07M -0.56M -2.59M -0.07M -0.05M
Net income from continuing ops - -0.10M -4.92M -1.52M -1.36M
Net income applicable to common shares - -0.08M -4.81M -1.45M -1.26M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 5.87M 3.34M 3.89M 5.47M 6.93M
Intangible assets - 0.01M - 0.10M 0.13M
Other current assets 0.81M 0.83M 0.45M 0.78M 0.69M
Total liab 6.29M 6.71M 4.74M 3.92M 3.95M
Total stockholder equity 1.12M -1.73M 0.57M 2.83M 4.10M
Other current liab 2.58M 2.86M 0.82M 1.18M 0.80M
Common stock 25.72M 21.87M 21.79M 21.79M 21.71M
Capital stock - - - 21.79M 21.71M
Retained earnings -24.70M -23.75M -21.12M -18.86M -17.41M
Other liab - - - 0.33M 0.28M
Other assets - - 0.00M 0.07M 0.08M
Cash 2.16M 0.02M 0.06M 0.12M 1.21M
Cash and equivalents - - - 0.12M 1.21M
Total current liabilities 5.88M 6.26M 3.80M 2.86M 3.16M
Current deferred revenue 0.26M - 0.56M 0.05M 0.01M
Net debt -0.57M 1.74M 1.51M 1.10M -0.32M
Short term debt 1.17M 1.32M 0.96M 0.50M 0.38M
Short long term debt - - - 0.47M 0.36M
Short long term debt total 1.59M 1.77M 1.57M 1.22M 0.89M
Other stockholder equity - 0.00M - -0.10M -0.20M
Property plant equipment - - - 1.23M 1.12M
Total current assets 5.11M 2.56M 2.85M 4.07M 5.59M
Net tangible assets - - - 2.72M 3.96M
Net receivables 1.04M 0.90M 1.68M 1.32M 2.41M
Long term debt - - - 0.47M 0.42M
Inventory 1.10M 0.81M 0.66M 1.41M 1.52M
Accounts payable 1.87M 2.08M 1.46M 1.13M 1.98M
Accumulated other comprehensive income 0.10M 0.15M -0.10M -0.10M -0.20M
Non currrent assets other - 0.00M 0.01M - -
Non current assets total 0.76M 0.78M 1.04M 1.41M 1.34M
Capital lease obligations - - - 0.28M 0.11M
Long term debt total - - - 0.72M 0.51M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments - 0.69M -0.05M -0.16M 0.09M
Change to liabilities - - - 0.00M 0.00M
Total cashflows from investing activities -0.18M 0.69M -0.05M -0.16M 0.05M
Net borrowings - 0.35M 4.92M 0.11M 0.11M
Total cash from financing activities 3.65M 0.14M 0.42M 0.19M 0.11M
Change to operating activities - - - - -0.05M
Net income -0.95M -0.10M -4.81M -1.52M -1.26M
Change in cash 2.14M -0.04M -0.06M -1.10M -1.51M
Begin period cash flow 0.02M 0.06M 0.12M 1.21M 2.73M
End period cash flow 2.16M 0.02M 0.06M 0.12M 1.21M
Total cash from operating activities -1.35M -1.01M -0.41M -1.25M -1.68M
Issuance of capital stock - - 0.00M 0.08M -
Depreciation 0.05M 0.10M 0.24M 0.27M 0.20M
Other cashflows from investing activities - 0.72M -0.04M -0.09M 0.09M
Change to inventory - -0.15M 0.75M - -
Change to account receivables - 0.10M 0.27M - -
Sale purchase of stock - 0.00M 0.00M 0.08M 0.00M
Other cashflows from financing activities -0.01M -0.21M -0.04M 4.05M 0.11M
Change to netincome - - - 0.06M -0.62M
Capital expenditures 0.18M 0.01M 0.00M 0.08M 0.04M
Change in working capital - -0.16M 1.42M 0.04M 0.10M
Stock based compensation - 0.03M - - -
Other non cash items -0.45M -0.85M 2.74M 1.25M 1.06M
Free cash flow -1.52M -1.02M -0.41M -1.33M -1.72M

Peer Comparison*

Sector: Consumer Defensive Industry: Packaged Foods

Stock Name
Change
(AUD)
Price
(AUD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
HCT
Holista Colltech Ltd
-
-%
0.03 - - 2.06 14.13 2.20 36.82
A2M
The a2 Milk Company Ltd
-0.07
0.96%
7.19 29.04 28.74 2.68 5.94 2.85 17.82
BGA
Bega Cheese Ltd
-0.02
0.30%
6.74 35.61 22.94 0.52 1.93 0.60 11.82
CBO
Cobram Estate Olives Ltd
-0.06
2.26%
2.59 - - 4.79 2.48 6.63 185.44
RIC
Ridley Corporation Ltd
0.02
0.74%
2.74 38.29 13.42 0.35 2.01 0.53 4.50

Profile*

Holista Colltech Ltd

Holista Colltech Limited operates as a research-driven biotech company in Australia, Malaysia, and the United States. The company operates through Supplements, Ovine Collagen, Infection Control Solutions, Food Ingredients, and Corporate segments. It manufactures and wholesales dietary supplements; cosmetic grade collagen; infection control solutions; and healthy food ingredients, including low-glycemic index (GI) bread, noodles/pasta, and flatbreads, as well as low-calorie/low-GI sugar substitutes. Further, it offers GI LiTE, a premix glycemic index reducer, and LOGIC, a sweetening solution alternative for health-conscious consumers. The company also offers biogenic particles, low fat chips, and water soluble technology. Holista Colltech Limited is based in Subiaco, Australia.

283 Rokeby Road, Subiaco, WA, Australia, 6008

61 2 8072 1400

Name Title Year Born
Dr. Rajendran Manickavasagar B Ph.(Hons) CEO, MD & Exec. Chairman NA
Mr. James Richard Stephenson CMA, CMA and FCIS, CPA, FCPA, FGIA, MAICD, MBA, P. CFO & Company Sec. 1966
Mee Ling Chin Chief Financial Officer NA
Mr. Bob Lee Chief Operating Officer NA
Ms. Yasmin Cheah Exec. Assistant to Chief Exec. Officer NA
Dr. Rajendran Manickavasagar B Ph.(Hons) CEO, MD & Non-independent Director NA
Mr. James Richard Stephenson C.A., C.M.A., C.P.A., CMA, CMA (Canada), CMA and F CFO & Company Secretary 1966
Dr. Rajendran Manickavasagar B Ph.(Hons) CEO, MD & Non-independent Director NA
Mr. James Richard Stephenson C.A., C.M.A., C.P.A., CMA, CMA (Canada), CMA and F CFO & Company Secretary 1966
Dr. Rajendran Manickavasagar B Ph.(Hons) CEO, MD & Non-independent Director NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…